Laurus Labs PAT at Rs 201.90 cr. in Q2FY21

Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021

Merck expands capacity for Antibody Drug Conjugate (ADC), therapies

Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges

Transforming Healthcare Through AI

KIMS Hospitals to acquire 51.07 % stake in Sunshine Hospitals

The combined entity will have 12 hospitals with 3,666 beds

Oasis Fertility forays into Karnataka plans 10 more centres

It plans to double its network to 50 centres across India in the next three years

Thermo Fisher Scientific unveils Q Digital PCR system

It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development

10x Genomics opens Singapore manufacturing hub

Strengthens supply chain continuity with first manufacturing facility outside of the U.S.

Biocon reports a consolidated net profit of Rs. 138.3 crore in Q2FY22

The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively

Biocon Q2FY22 in line with estimates, better margins: ICICI Direct

Key takeaways of recent quarter & conference call highlights

Boehringer Ingelheim and partners to develop gene therapy for patients with cystic fibrosis

It has exercised intellectual property options from IP Group regarding research results generated by the UK Cystic Fibrosis Gene Therapy Consortium, and from Oxford Biomedica regarding their lentiviral vector technology